{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:14:15Z","timestamp":1783444455446,"version":"3.54.6"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.mrgentox.2021.503388","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T12:03:23Z","timestamp":1627387403000},"page":"503388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Genotoxicity test battery \u2013 An assessment of its utility in early drug development"],"prefix":"10.1016","volume":"868-869","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3009-3354","authenticated-orcid":false,"given":"Paul","family":"Baldrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrgentox.2021.503388_bib0005","unstructured":"International Conference on Harmonisation: Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use, ICH S2(R1) 2011; https:\/\/database.ich.org\/sites\/default\/files\/S2%28R1%29%20Guideline.pdf (accessed June 2021)."},{"key":"10.1016\/j.mrgentox.2021.503388_bib0010","series-title":"Global Approach in Safety Testing: ICH Guidelines Explained. AAPS Advances in the Pharmaceutical Sciences Series 5","first-page":"77","article-title":"The evolution, scientific reasoning and use of ICH S2 guidelines for genotoxicity of pharmaceuticals","author":"M\u00fcller","year":"2013"},{"key":"10.1016\/j.mrgentox.2021.503388_bib0015","unstructured":"International Conference on Harmonisation: Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorisation for Pharmaceuticals, ICH M3(R2) 2009; https:\/\/database.ich.org\/sites\/default\/files\/M3_R2__Guideline.pdf (accessed June 2021)."},{"key":"10.1016\/j.mrgentox.2021.503388_bib0020","unstructured":"International Conference on Harmonization: Nonclinical Evaluation for Anticancer Pharmaceuticals, ICH S9 2010; https:\/\/database.ich.org\/sites\/default\/files\/S9_Guideline.pdf (accessed June 2021)."},{"key":"10.1016\/j.mrgentox.2021.503388_bib0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.yrtph.2008.04.006","article-title":"Safety evaluation to support first-in-man investigations II: toxicology studies","volume":"51","author":"Baldrick","year":"2008","journal-title":"Reg. Tox. Pharm."},{"key":"10.1016\/j.mrgentox.2021.503388_bib0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yrtph.2017.07.027","article-title":"Getting a molecule into the clinic: nonclinical testing and starting dose considerations","volume":"89","author":"Baldrick","year":"2017","journal-title":"Reg. Tox. Pharm."},{"key":"10.1016\/j.mrgentox.2021.503388_bib0035","first-page":"764","article-title":"Use of \u201cBig Data\u201d to evaluate responses to changes in regulatory guidelines: trends in genotoxicity testing packages for new pharmaceutical products","volume":"54","author":"Reeve","year":"2020","journal-title":"TIRS"},{"key":"10.1016\/j.mrgentox.2021.503388_bib0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mrgentox.2006.11.008","article-title":"How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM Workshop","volume":"628","author":"Kirkland","year":"2007","journal-title":"Mutat. Res."},{"issue":"6","key":"10.1016\/j.mrgentox.2021.503388_bib0045","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/mutage\/geq046","article-title":"Analysis of published data for top concentration considerations in mammalian cell genotoxicity testing","volume":"25","author":"Parry","year":"2010","journal-title":"Mutagen"},{"key":"10.1016\/j.mrgentox.2021.503388_bib0050","series-title":"Guidance for Industry and Review Staff Recommended Approaches to Integration of Genetic Toxicology Study Results","author":"Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER)","year":"2006"},{"key":"10.1016\/j.mrgentox.2021.503388_bib0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1383-5718(98)00004-7","article-title":"Transient hypothermia induces micronuclei in mice","volume":"413","author":"Asanami","year":"1998","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrgentox.2021.503388_bib0060","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/mutage\/gew013","article-title":"Genotoxicity assessment of peptide\/protein-related biotherapeutics: points to consider before testing","volume":"31","author":"Thybaud","year":"2016","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2021.503388_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yrtph.2020.104766","article-title":"Development of peptide therapeutics: a nonclinical safety assessment perspective","volume":"117","author":"Mitra","year":"2020","journal-title":"Reg. Tox. Pharm."}],"container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571821000796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571821000796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:06:39Z","timestamp":1761300399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383571821000796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":13,"alternative-id":["S1383571821000796"],"URL":"https:\/\/doi.org\/10.1016\/j.mrgentox.2021.503388","relation":{},"ISSN":["1383-5718"],"issn-type":[{"value":"1383-5718","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genotoxicity test battery \u2013 An assessment of its utility in early drug development","name":"articletitle","label":"Article Title"},{"value":"Mutation Research\/Genetic Toxicology and Environmental Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrgentox.2021.503388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"503388"}}